Memory-window engineering: target specifications for duration, retention through division, and amplitude in immune epigenome editing
Year: 2026
Type: article
Abstract: Immune activation, tolerance, exhaustion, trained immunity and regulatory stability are held in place by chromatin accessibility, DNA methylation, histone modification, and enhancer-promoter wiring. CRISPR-based epigenome editors rewrite these layers without cutting DNA, but most reports address editing efficiency and leave time unanswered. Target duration is a design input to be specified before an editor is chosen; the duration achieved remains an experimental outcome. Memory-window engineering defines a candidate immune edit by three parameters: duration after editor clearance, retention through cell division, and amplitude at single-cell resolution, with target-compartment division rate as an explicit modifier. For passively diluted marks, division rate constrains post-clearance duration; transcriptional and phenotypic persistence may follow different trajectories. Published results from methylation editing at IL1RN, FOXP3 enhancer demethylation, PD-1 enhancer tuning, exhaustion circuits and CRISPRoff programming of primary human T cells are interpreted using their readouts and observation windows; some persistence endpoints remain censored by study duration. Three testable predictions concern CpG density, transcript-versus-mark recovery and division-dependent loss, with competing mechanisms and measurement artefacts considered. Specificity, the nuclease-knockout comparison, and the ethics of durable edits are treated as parts of the same specification. Two design consequences follow. TET-dependent erasure requires oxygen and 2-oxoglutarate; reduced erasure in hypoxic or metabolically inhibitory tumour regions is therefore a hypothesis for edited immune cells. Sustained programming of circulating monocyte output requires an upstream progenitor strategy, whereas long-lived resident myeloid cells are a separate case. A worked CAR T example and five-item reporting minimum distinguish development-stage characterisation from lot-release testing.
Source: Frontiers in Immunology
Author: Jack Riegler
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: immunological memory, histone modifications, enhancer demethylation, T cell exhaustion, trained immunity, chromatin accessibility, cell division, alpha-ketoglutarate, hypoxia, chimeric antigen receptor T cells, monocytes, interleukin-1 receptor antagonist, nuclease specificity, lot release testing
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226039752
